Compare EXAS & RGTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXAS | RGTI |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.9B |
| IPO Year | N/A | N/A |
| Metric | EXAS | RGTI |
|---|---|---|
| Price | $101.54 | $26.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 6 |
| Target Price | ★ $77.94 | $28.33 |
| AVG Volume (30 Days) | 10.8M | ★ 42.9M |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,082,033,000.00 | $7,494,000.00 |
| Revenue This Year | $19.40 | N/A |
| Revenue Next Year | $13.51 | $166.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.47 | N/A |
| 52 Week Low | $38.81 | $5.78 |
| 52 Week High | $101.95 | $58.15 |
| Indicator | EXAS | RGTI |
|---|---|---|
| Relative Strength Index (RSI) | 89.64 | 44.96 |
| Support Level | $100.95 | $24.73 |
| Resistance Level | $101.95 | $30.21 |
| Average True Range (ATR) | 0.34 | 2.11 |
| MACD | -0.87 | 0.53 |
| Stochastic Oscillator | 59.71 | 46.48 |
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.